This research uses immune cell “molecular fingerprints” to rapidly detect cancer from a single drop of blood. By combining nanosensors and machine learning, subtle changes in B cells can be identified within minutes. The approach offers fast, accurate, and low-cost cancer detection with the potential to significantly improve early diagnosis and survival.

Prion diseases like CJD are extremely hard to detect early because harmful prions resemble normal brain proteins. This research introduces a new “flashbody” detection tool that binds only disease-causing prions, providing rapid, accurate, equipment-free diagnosis. Early lab results and patient-screening trials are promising, with potential applications to Alzheimer’s and other dementias.